دورية أكاديمية
Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience.
| العنوان: | Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience. |
|---|---|
| المؤلفون: | Ekhlaspour, Laya, Buckingham, Bruce, Bauza, Colleen, Clements, Mark, Forlenza, Gregory P, Neyman, Anna, Norlander, Lisa, Schamberger, Marcus, Sherr, Jennifer L, Bailey, Ryan, Beck, Roy W, Kollman, Craig, Beasley, Shannon, Cobry, Erin, DiMeglio, Linda A, Paprocki, Emily, Van Name, Michelle, Moran, Antoinette |
| المصدر: | J Clin Transl Endocrinol ; ISSN:2214-6237 ; Volume:36 |
| بيانات النشر: | PubMed Central |
| سنة النشر: | 2024 |
| المجموعة: | PubMed Central (PMC) |
| مصطلحات موضوعية: | Children, Newly diagnosed, Safety, Type 1 diabetes, Verapamil |
| الوصف: | To report the safety and side effects associated with taking verapamil for beta-cell preservation in children with newly-diagnosed T1D. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://doi.org/10.1016/j.jcte.2024.100352Test; https://pubmed.ncbi.nlm.nih.gov/38860154Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163172Test/ |
| DOI: | 10.1016/j.jcte.2024.100352 |
| الإتاحة: | https://doi.org/10.1016/j.jcte.2024.100352Test https://pubmed.ncbi.nlm.nih.gov/38860154Test https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163172Test/ |
| حقوق: | © 2024 The Authors. |
| رقم الانضمام: | edsbas.E4BA0926 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.jcte.2024.100352 |
|---|